Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced the appointment of Jody Thompson to the role of senior vice president of business development, rare disease.
Health Technology Insights: MaxHSA and Avidia Health Announce Strategic Partnership to Help Increase HSA Deposits
Thompson will augment the strategy to broaden Soleo Health’s portfolio of exclusive and limited distribution therapies for rare, ultra-rare and orphan diseases. These conditions affect fewer than 200,000 people in the United States, nearly half of whom are children. By building key industry partnerships, Thompson will amplify Soleo Health’s established rare disease expertise to focus on serving a small, underserved population facing some of the most complex healthcare challenges.
Thompson joins Soleo with an extensive background as a pharmaceutical healthcare executive and a proven track record of successfully commercializing multiple rare disease products in the United States. Prior to joining Soleo Health, she held key leadership roles in market access, patient support, and hub services, with a focus on the rare disease space.
Health Technology Insights: PAICON Advances Global Cancer AI With Diverse Data
“I’m excited to join Soleo Health and advance its mission of delivering rare disease therapies to patients who need them most,” said Thompson. “We have an incredible opportunity to make a meaningful impact on patient care and outcomes.”
“Jody’s wealth of experience and leadership in successfully commercializing life-changing therapies will be instrumental as we expand our portfolio of rare and orphan therapies,” stated Drew Walk, Soleo Health chief executive officer. “Soleo Health has been dedicated to supporting patients with rare and orphan diseases since our inception, and this strategic role underscores our ongoing commitment to our pharma, payor, provider partners and the patients we serve together.”
Health Technology Insights: Jesper Høiland Joins Alva Therapeutics Board
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
Source- GlobeNewswire
